|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-2-11
|
|
pubmed:abstractText |
In the FRISC trial, dalteparin 120 IU/kg body weight twice daily for unstable coronary artery disease was safe and reduced the risk of new coronary events. This risk reduction was maintained during the following extended treatment with a fixed dose of 7500 IU dalteparin once daily.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-8703
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
137
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
72-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9878938-Adult,
pubmed-meshheading:9878938-Angina, Unstable,
pubmed-meshheading:9878938-Anticoagulants,
pubmed-meshheading:9878938-Blood Coagulation,
pubmed-meshheading:9878938-Coronary Disease,
pubmed-meshheading:9878938-Dalteparin,
pubmed-meshheading:9878938-Drug Administration Schedule,
pubmed-meshheading:9878938-Female,
pubmed-meshheading:9878938-Humans,
pubmed-meshheading:9878938-Linear Models,
pubmed-meshheading:9878938-Male,
pubmed-meshheading:9878938-Middle Aged,
pubmed-meshheading:9878938-Myocardial Infarction,
pubmed-meshheading:9878938-Sex Factors,
pubmed-meshheading:9878938-Smoking,
pubmed-meshheading:9878938-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Influences of sex and smoking habits on anticoagulant activity in low-molecular-weight heparin treatment of unstable coronary artery disease.
|
|
pubmed:affiliation |
Department of Cardiology, University Hospital, Uppsala, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
